We are live on ! Find out more
ICUI icon

ICU Medical

344 hedge funds and large institutions have $4.4B invested in ICU Medical in 2018 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 105 increasing their positions, 115 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 20

108% more call options, than puts

Call options by funds: $31.6M | Put options by funds: $15.2M

18% more funds holding

Funds holding: 291344 (+53)

17% more capital invested

Capital invested by funds: $3.77B → $4.4B (+$635M)

0.86% more ownership

Funds ownership: 73.85%74.71% (+0.86%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

9% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 115

Holders
344
Holders Change
+53
Holders Change %
+18.21%
% of All Funds
7.88%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
75
Increased
105
Reduced
115
Closed
20
Calls
$31.6M
Puts
$15.2M
Net Calls
+$16.4M
Net Calls Change
+$14M
Name Holding Trade Value Shares
Change
Change in
Stake
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$400M -$3.39M -12,411 -0.9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$389M +$4.54M +16,603 +1%
BlackRock
3
BlackRock
New York
$388M -$87.8M -321,354 -20%
Millennium Management
4
Millennium Management
New York
$199M +$35.7M +130,580 +24%
JP Morgan Chase
5
JP Morgan Chase
New York
$151M +$10.9M +39,913 +8%
Wells Fargo
6
Wells Fargo
California
$129M -$4.8M -17,556 -4%
State Street
7
State Street
Massachusetts
$127M -$24.6M -90,157 -17%
GKIM
8
GW&K Investment Management
Massachusetts
$124M -$10.8M -39,691 -9%
Renaissance Technologies
9
Renaissance Technologies
New York
$91.8M +$929K +3,400 +1%
SAM
10
Silvercrest Asset Management
New York
$89M -$15.6M -57,230 -16%
Invesco
11
Invesco
Georgia
$87.4M +$11.6M +42,477 +17%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$74.3M +$3.64M +13,306 +6%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$67.5M -$23.1M -84,590 -27%
O
14
OppenheimerFunds
New York
$66.3M +$22.7M +82,976 +58%
Goldman Sachs
15
Goldman Sachs
New York
$61.8M -$17.2K -63 -0%
Fiera Capital (Canada)
16
Fiera Capital (Canada)
Quebec, Canada
$60.5M -$993K -3,633 -2%
Wellington Management Group
17
Wellington Management Group
Massachusetts
$58.8M +$3.07M +11,217 +6%
RG
18
Redmile Group
California
$54.1M -$2.54M -9,300 -5%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$53M -$5.4M -19,769 -10%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$50.9M -$775K -2,837 -2%
Norges Bank
21
Norges Bank
Norway
$49.9M -$2.9M -10,606 -6%
CIP
22
Champlain Investment Partners
Vermont
$46M -$19.6M -71,645 -31%
GT
23
Glenmede Trust
Pennsylvania
$45.9M -$3.63M -13,271 -8%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$43.8M +$1.99M +7,265 +5%
Northern Trust
25
Northern Trust
Illinois
$43.2M -$27.3M -99,829 -40%

ICUI Hedge Fund Activity: Q2 2018 in Review

344 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q2 2018, worth a combined $4.4B — up 17% from $3.77B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new ICUI positions and 20 closed out — a net gain of 55 holders — while 105 added to existing stakes and 115 trimmed.

The largest buyer was Millennium Management, adding an estimated $35.7M. The largest seller was BlackRock, cutting an estimated $87.8M.

  • 344 institutional investors held ICU Medical (ICUI) as of Q2 2018, up from 291 in Q1 2018.
  • Funds reported $4.4B of ICU Medical stock for Q2 2018, up 17% quarter-over-quarter.
  • 75 funds opened new ICU Medical positions in Q2 2018 and 20 closed out, a net change of +55 holders.
  • The largest ICU Medical buyer in Q2 2018 was Millennium Management, an estimated $35.7M added.
  • The largest ICU Medical seller in Q2 2018 was BlackRock, an estimated $87.8M sold.

Based on aggregated 13F filings for Q2 2018.